Spatial T lymphocyte infiltration into the primary melanoma tumor associates with survival

Tumor infiltrating lymphocyte grade is a prognostic indicator for patients with cutaneous invasive primary melanoma and assigned one of three-levels (brisk, nonbrisk, or absent). We sought to develop objective, quantitative measures of T lymphocyte subtypes spatially within the tumor microenvironment. We applied multiplex whole-slide immunohistochemistry/immunofluorescence to 80 melanomas, using S100 to identify tumor cells (S100+) and CD3 and CD8 to identify noncytotoxic T lymphocytes (CD3+CD8-), cytotoxic CD8+ T lymphocytes (CD3+CD8+), and total T lymphocytes (CD3+CD8- plus CD3+CD8+). We used image analysis to spatially locate the T lymphocyte subtypes within the whole tumor, the tumor center (175 µm into the tumor), and the tumor margin (within 100 µm outside the tumor). T lymphocyte subtypes were quantified for density as CD3+CD8- and CD3+CD8+ cells colocalized with intact nuclei/µm2. Melanoma-specific survival, adjusted for American Joint Committee on Cancer eighth edition stage, improved when a higher density of each T lymphocyte subtype (CD3+CD8-; CD3+CD8+) infiltrated 175 µm into the tumor center or total T lymphocytes infiltrated into the whole tumor (hazard ratios: 0.72-0.77; all P < 0.05). Improved melanoma-specific survival is significantly associated with high density of CD3+CD8- T lymphocytes in the margin after stage adjustment. Our results indicate spatial location of T lymphocyte subset infiltration within the tumor microenvironment is important for predicting melanoma-specific survival.

Authors

Institutions

Publication Details

Journal
Melanoma Research
Published
2026-07-28
DOI
https://doi.org/10.1097/cmr.0000000000001127
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Spatial T lymphocyte infiltration into the primary melanoma tumor associates with survival

Paul B. Googe, Nancy E. Thomas, Pei Fen Kuan, David L. Corcoran et al.
Melanoma Research
Cancer Immunotherapy and Biomarkers
article

Spatial T lymphocyte infiltration into the primary melanoma tumor associates with survival

Paul B. Googe, Nancy E. Thomas, Pei Fen Kuan, David L. Corcoran, Yi‐Hsuan Tsai, Eloise Parrish, D. W. Ollila, Sharon N. Edmiston, Honglin Hao, Ronglai Shen, Kathleen Conway
article en

Abstract

Tumor infiltrating lymphocyte grade is a prognostic indicator for patients with cutaneous invasive primary melanoma and assigned one of three-levels (brisk, nonbrisk, or absent). We sought to develop objective, quantitative measures of T lymphocyte subtypes spatially within the tumor microenvironment. We applied multiplex whole-slide immunohistochemistry/immunofluorescence to 80 melanomas, using S100 to identify tumor cells (S100+) and CD3 and CD8 to identify noncytotoxic T lymphocytes (CD3+CD8-), cytotoxic CD8+ T lymphocytes (CD3+CD8+), and total T lymphocytes (CD3+CD8- plus CD3+CD8+). We used image analysis to spatially locate the T lymphocyte subtypes within the whole tumor, the tumor center (175 µm into the tumor), and the tumor margin (within 100 µm outside the tumor). T lymphocyte subtypes were quantified for density as CD3+CD8- and CD3+CD8+ cells colocalized with intact nuclei/µm2. Melanoma-specific survival, adjusted for American Joint Committee on Cancer eighth edition stage, improved when a higher density of each T lymphocyte subtype (CD3+CD8-; CD3+CD8+) infiltrated 175 µm into the tumor center or total T lymphocytes infiltrated into the whole tumor (hazard ratios: 0.72-0.77; all P < 0.05). Improved melanoma-specific survival is significantly associated with high density of CD3+CD8- T lymphocytes in the margin after stage adjustment. Our results indicate spatial location of T lymphocyte subset infiltration within the tumor microenvironment is important for predicting melanoma-specific survival.

Melanoma Research
University of North Carolina at Chapel Hill (US), State University of New York (US), Memorial Sloan Kettering Cancer Center (US), Comprehensive Blood & Cancer Center (US), CytomX Therapeutics (United States) (US), Stony Brook University (US)
Openalex Percentile: Top 11%
Cancer Immunotherapy and Biomarkers
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.